An application was made to vary the product licence for Kryobulin, in order to allow for the use of radioimmunoassay (RIA) testing for Hepatitis B antigen.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates